Institut Paoli Calmettes Multiple Myeloma Database
Recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- NCT02869555
- Lead Sponsor
- Institut Paoli-Calmettes
- Brief Summary
- Database of Institut Paoli-Calmettes patients diagnosed with multiple myeloma 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
- Multiple myeloma diagnosis
Exclusion Criteria
- Diagnosis before 1st january 2008
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Survival of patients - 10 years - Overall survival of all patients who come in the center 
- Secondary Outcome Measures
- Name - Time - Method - Collection of patients characteristics - 10 years - Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms are being studied in the NCT02869555 multiple myeloma database for potential drug targets?
How does the Institut Paoli Calmettes database compare standard-of-care treatments for multiple myeloma subtypes?
What biomarkers are associated with treatment response in the NCT02869555 observational multiple myeloma study?
What adverse events are reported in the NCT02869555 database for multiple myeloma patients and their management?
What combination therapies or competitor drugs are being evaluated alongside the NCT02869555 multiple myeloma database?
Trial Locations
- Locations (1)
- Institut Paoli-Calmettes 🇫🇷- Marseille, Bouches-du Rhône, France Institut Paoli-Calmettes🇫🇷Marseille, Bouches-du Rhône, FranceDominique GENRE, MDContact+33 4 91 22 37 78drci.up@ipc.unicancer.fr
